Subcutaneous IGF-1 is not beneficial in 2-year als trial

Charles L. Howe; Rachel A. Bergstrom; Bruce F. Horazdovsky

doi:10.1212/WNL.0b013e3181b26ae6

Subcutaneous IGF-1 is not beneficial in 2-year als trial

Charles L. Howe, Rachel A. Bergstrom, Bruce F. Horazdovsky

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1247-1248
Number of pages	2
Journal	Neurology
Volume	73
Issue number	15
DOIs	https://doi.org/10.1212/WNL.0b013e3181b26ae6
State	Published - Oct 2009

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/WNL.0b013e3181b26ae6

Cite this

@article{d4e87a94f97847589ffc986380a167b7,

title = "Subcutaneous IGF-1 is not beneficial in 2-year als trial",

author = "Howe, {Charles L.} and Bergstrom, {Rachel A.} and Horazdovsky, {Bruce F.}",

year = "2009",

month = oct,

doi = "10.1212/WNL.0b013e3181b26ae6",

language = "English (US)",

volume = "73",

pages = "1247--1248",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "15",

}

TY - JOUR

T1 - Subcutaneous IGF-1 is not beneficial in 2-year als trial

AU - Howe, Charles L.

AU - Bergstrom, Rachel A.

AU - Horazdovsky, Bruce F.

PY - 2009/10

Y1 - 2009/10

UR - http://www.scopus.com/inward/record.url?scp=70350146791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350146791&partnerID=8YFLogxK

U2 - 10.1212/WNL.0b013e3181b26ae6

DO - 10.1212/WNL.0b013e3181b26ae6

M3 - Letter

C2 - 19822878

AN - SCOPUS:70350146791

SN - 0028-3878

VL - 73

SP - 1247

EP - 1248

JO - Neurology

JF - Neurology

IS - 15

ER -

Subcutaneous IGF-1 is not beneficial in 2-year als trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this